Compounded tirzepatide
Embody vs Teleios Health
Quick answer
Teleios Health costs $99 a real month and Embody costs $129 — a difference of $30 a month, or $360 a year. Both figures are computed from what each seller actually charges and how often, not from the price on its landing page.
What each one bills
| Embody | Teleios Health | |
|---|---|---|
| True monthly cost | $129 | $99 |
| Advertised as | $129 | $99 |
| Charged | every calendar month | every calendar month |
| Each charge | $129 | $99 |
| Price basis | the same at every dose | not stated |
| Mandatory recurring fee | none found | none found |
| States it names | 50 states | not published |
| FDA warning letter | none on record | none on record |
We earn a commission if you start care through one of the links above, at no extra cost to you. Which of these two is cheaper is computed from what each one bills and nothing else.
Where they actually differ
- One price holds and the other climbs. Embody’s price is the same at every dose; Teleios Health’s is not stated. See what titration does to an advertised figure.
How we know
Both figures were read on the seller’s own site and recomputed over a 30.4375-day calendar month from the charge and the billing period it covers. Neither is a seller’s own “/mo”. The full working for each — the charge, the period, the arithmetic and the date it was read — is on its own page: Embody and Teleios Health. The method is set out in how we verify.
To compare any two sellers in the index rather than these two, use the comparison tool.